SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs agreement to acquire low-band spectrum for Starlink Mobile sparked a sharp selloff in T-Mobile and other wireless carriers as traders weighed the prospect of a new competitor. The community is divided between seeing a meaningful long-term threat and calling the reaction excessive because building a competitive network would take substantial time and investment.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs agreement to acquire low-band spectrum for Starlink Mobile has intensified concerns about future competition, weighing on AT&T and other major wireless carriers. Traders are split between viewing the sharp selloff as an overreaction given the time and infrastructure needed to build a rival network and seeing a credible long-term threat; some are buying the dip for AT&Ts dividend.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is drawing attention amid a steep, sustained share-price decline that investors say lacks a clear explanation, with frustration focused on managements limited communication. The debate centers on whether Auvelitys Alzheimers agitation launch is gaining traction: bulls cite rising prescriptions and possible data undercounting, while skeptics question whether uptake is accelerating enough to support growth and a path to profitability.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax rallied alongside vaccine peers after reports of an NIH push to accelerate personalized cancer vaccines, with traders noting the move was largely sector-wide sympathy buying rather than a company-specific oncology announcement. The community also debated whether heavy short interest could amplify the move, while some pointed to Sanofis combination-vaccine trial as a separate potential catalyst.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunruns distributed AI-computing pilot, which would use customers solar-and-battery-equipped homes to host computing nodes, is driving attention and enthusiasm about a new data-center power opportunity. Traders are debating whether the concept can generate meaningful revenue, since the rollout is early and its economics remain unclear.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the following business segments: Consumer and Business. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

SpaceXs planned acquisition of low-band spectrum for Starlink Mobile has raised fears that it could eventually compete with Verizon and other U.S. wireless carriers, weighing heavily on telecom shares. Traders are divided between viewing the move as a long-term threat and calling the selloff an overreaction given the years of investment and infrastructure needed to build a competing network; some see Verizons dividend and cash flows as support.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is rallying to fresh highs amid strength in software stocks, with traders highlighting its breakout and momentum. Bulls point to AI-related observability demand, while skeptics warn that the valuation is stretched and the move could reverse.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry and a reported NIH effort to accelerate personalized cancer vaccines have fueled buying, alongside optimism about its partnered mRNA melanoma-vaccine program with Merck. Traders are divided over whether index-related demand and cancer-vaccine hopes justify the sharp run, with skeptics pointing to valuation and ongoing losses and warning of a pullback.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

A joint request to extend claim-construction briefing deadlines in Aurinias generic-voclosporin patent litigation has fueled speculation that settlements may be nearing, though none is confirmed. Traders welcomed the share-price rebound, while others expect it to fade and remain frustrated by continued delays and limited company updates.

WorldFinancial

Speculation that USD1s use at the UFC Freedom 250 event could boost attention to WLFI is drawing bullish calls for a squeeze, alongside recurring hopes that the bank-charter development will add utility. Skeptics counter that WLFI has lagged other crypto assets and question whether these developments will benefit token holders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?

Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.

Cryoport (CYRX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

CryoPort (CYRX) Upgraded to Buy: Here's Why

CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

CryoPort (CYRX) delivered earnings and revenue surprises of 0.00% and +1.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cryoport Reports Second Quarter 2026 Financial Results

Cryoport Reports Second Quarter 2026 Financial Results Cryoport Reports Second Quarter 2026 Financial Results PR Newswire NASHVILLE, Tenn., Aug. 6, 2026 Second quarter revenue grew 8% year-over-year to $49.0 millionLife Sciences Services revenue increased 15% year-over-yearBioStorage/BioServices...

Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2

Caris Life Sciences,?Inc. (CAI) delivered earnings and revenue surprises of +100.00% and +14.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026

Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026 Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire NASHVILLE, Tenn., July 23, 2026 NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ -- Cryoport, Inc.(Nasdaq: CYRX) ("Cryoport" or the...

Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs

Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs PR Newswire NASHVILLE, Tenn...

CryoPort (NASDAQ:CYRX) Hits New 12-Month High on Analyst Upgrade

CryoPort (NASDAQ:CYRX) Sets New 1-Year High on Analyst Upgrade...

CryoPort (NASDAQ:CYRX) Shares Gap Up  on Analyst Upgrade

CryoPort (NASDAQ:CYRX) Shares Gap Up Following Analyst Upgrade...

Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

CryoPort Inc

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$17.35
Prev Close	$16.90
Open	$16.90
Dividend Yield	0.00%
50-Day Moving Average	$16.27
Beta	1.78
Avg. Volume	600,541.03
PE Ratio	-21.24

52-Week High	$18.36
52-Week Low	$7.61
Market Capitalization	$855.97M
EPS (Annual)	-$0.9317
Price to Book	1.98
Revenue Per Employee	$238,722.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

CYRX Fundamentals